Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating dysmenorrhoea

A composition and medicine technology, applied in the field of western medicine, can solve the problems of harming the health of patients, cannot be completely cured, poor taste, etc., and achieve the effects of reducing medical costs, reducing medical expenses, and simple production.

Inactive Publication Date: 2017-05-31
郑州莉迪亚医药科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the existing Chinese medicine for the treatment of dysmenorrhea has the shortcoming of long curative effect, slow effect and poor mouthfeel, and it is difficult for the patient to persist; while the existing western medicine has quick effect and short curative effect, but it cannot be completely cured, and the patient will produce certain medicine Dependence, many patients also have side effects and complications, seriously endangering the health of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A pharmaceutical composition for treating dysmenorrhea, consisting of the following raw materials in parts by weight: 2 parts of acetaminophen, 2 parts of sulpiride, 0.1 part of atropine, 0.8 part of EGCG, 1 part of citric acid, 0.1 part of chlordiazepoxide, 5 parts of olive oil 2 parts of chlorpromazine hydrochloride, 0.2 parts of vitamin p, 1 part of earthworm protein powder, 5 parts of donkey-hide gelatin, 1 part of diclofenac sodium, 2 parts of vitamin E, 2 parts of glucocorticoid drugs, and 80 parts of normal saline.

[0026] The glucocorticoid drug is compound betamethasone.

[0027] A preparation method of a pharmaceutical composition for treating dysmenorrhea, the specific steps are:

[0028] (1) each raw material is taken by weighing, for subsequent use;

[0029] (2) Crushed: acetaminophen, sulpiride, atropine, EGCG, citric acid, chlornitrogen, olive oil, chlorpromazine hydrochloride, vitamin P, earthworm protein powder, diclofenac sodium, vitamin E, glucocort...

Embodiment 2

[0036] A pharmaceutical composition for treating dysmenorrhea, consisting of the following raw materials in parts by weight: 5 parts of acetaminophen, 5 parts of sulpiride, 2 parts of atropine, 5 parts of EGCG, 5 parts of citric acid, 1 part of chlordiazepoxide, and 10 parts of olive oil 5 parts of chlorpromazine hydrochloride, 1 part of vitamin p, 5 parts of earthworm protein powder, 9 parts of donkey-hide gelatin, 5 parts of diclofenac sodium, 8 parts of vitamin E, 5 parts of glucocorticoid drugs, and 150 parts of normal saline.

[0037] The glucocorticoid medicine is hydrocortisone.

[0038] A preparation method of a pharmaceutical composition for treating dysmenorrhea, the specific steps are:

[0039] (1) each raw material is taken by weighing, for subsequent use;

[0040] (2) Crushed: acetaminophen, sulpiride, atropine, EGCG, citric acid, chlornitrogen, olive oil, chlorpromazine hydrochloride, vitamin P, earthworm protein powder, diclofenac sodium, vitamin E, glucocortic...

Embodiment 3

[0047] A pharmaceutical composition for treating dysmenorrhea, consisting of the following raw materials in parts by weight: 4 parts of acetaminophen, 3 parts of sulpiride, 0.5 parts of atropine, 2 parts of EGCG, 3 parts of citric acid, 0.2 parts of chlordiazepoxide, 6 parts of olive oil 4 parts of chlorpromazine hydrochloride, 0.5 parts of vitamin p, 3 parts of earthworm protein powder, 8 parts of donkey-hide gelatin, 4 parts of diclofenac sodium, 6 parts of vitamin E, 4 parts of glucocorticoid drugs, and 105 parts of normal saline.

[0048] The glucocorticoid drug is fluocinolone.

[0049] A preparation method of a pharmaceutical composition for treating dysmenorrhea, the specific steps are:

[0050] (1) each raw material is taken by weighing, for subsequent use;

[0051] (2) Crushed: acetaminophen, sulpiride, atropine, EGCG, citric acid, chlornitrogen, olive oil, chlorpromazine hydrochloride, vitamin P, earthworm protein powder, diclofenac sodium, vitamin E, glucocorticoid...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating dysmenorrhoea. The pharmaceutical composition comprises the following raw materials in parts by weight: 2-5 parts of paracetamol, 2-5 parts of sulpiride, 0.1-2 parts of atropine, 0.8-5 parts of EGCG, 1-5 parts of citric acid, 0.1-1 part of chlorine nitrogen, 5-10 parts of olive oil, 2-5 parts of chlorpromazine hydrochloride, 0.2-1 part of vitamin p, 1-5 parts of earthworm protein powder, 5-9 parts of donkey-hide gelatin, 1-5 parts of diclofenac sodium, 2-8 parts of vitamin E, 2-5 parts of glucocorticoid medicine, and 80-150 parts of physiological saline. The pharmaceutical composition for treating dysmenorrhoea develops a synergistic effect by means of combination of the raw materials, is capable of effectively treating symptoms such as stomachache, soreness and weakness of waist, and cool hands and feet during menstruation, and is simple to prepare and low in production cost. The medicine is capable of thoroughly treating both manifestation and root cause of dysmenorrhoea without causing drug dependence of a patient, and is low in side effects without complication.

Description

technical field [0001] The invention relates to the technical field of western medicine, in particular to a pharmaceutical composition for treating dysmenorrhea. Background technique [0002] Dysmenorrhea is one of the most common gynecological symptoms. It refers to those who experience lower abdominal pain and swelling before and after menstruation or during menstruation, accompanied by backache or other discomforts. The symptoms seriously affect the quality of life. Dysmenorrhea is divided into two types: primary dysmenorrhea and secondary dysmenorrhea. Primary dysmenorrhea refers to dysmenorrhea without organic lesions in reproductive organs, accounting for more than 90% of dysmenorrhea; secondary dysmenorrhea refers to dysmenorrhea caused by pelvic organic diseases. [0003] The causes of dysmenorrhea include: 1) The occurrence of primary dysmenorrhea is mainly related to the increase of prostaglandin content in the endometrium during menstruation. The main cause of dys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/01A61P15/00A61K31/5513A61K36/32A61K35/36A61K31/7048A61K31/58A61K31/573A61K31/5415A61K31/46A61K31/40A61K31/355A61K31/353A61K31/196A61K31/194A61K31/167A61K35/62
CPCA61K31/167A61K31/194A61K31/196A61K31/353A61K31/355A61K31/40A61K31/46A61K31/5415A61K31/5513A61K31/573A61K31/58A61K31/7048A61K35/36A61K35/62A61K36/32A61K38/012A61K2300/00
Inventor 不公告发明人
Owner 郑州莉迪亚医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products